Evidence map›Paper›PMID 37336824›Full record

ArticleNeurochemical research2023

VCAM-1

Xiao Zhang, Xiaoyu Sang, Yanting Chen, Hao Yu, Yuan Sun, Xilong Liang, Xiaolei Zheng, Xiao Wang, Hui Yang, Jianzhong Bi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. VCAM-1Neurochemical research · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Xiao ZhangDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China.
Xiaoyu SangDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China.
Yanting ChenDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China.
Hao YuSchool of Medicine, Nankai University, Tianjin, 300071, China.
Yuan SunThe Second Hospital of Shandong University, Jinan, 250033, China.
Xilong LiangDepartment of Biostatistics, School of Public Health, Yale University, 38 Crown Street, APT 203, New Haven, CT, 06510, USA.
Xiaolei ZhengDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China.
Xiao WangDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China.
Hui YangDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China.
Jianzhong BiDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China.
Leisheng ZhangDepartment of Neurosurgery, Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250014, China. leisheng_zhang@163.com.
Ping WangDepartment of Neurology, The Second Hospital of Shandong University, Jinan, 250033, China. wping0108@163.com.
Second Hospital of Shandong University · CNNankai University · CNShandong First Medical University · CNYale University · US

Funding

Foundation of the Second Hospital of Shandong University (2022YP93)Jiangxi Provincial Natural Science Foundation (20224BAB206077, 20212BAB216073)Jinan clinical medical science and technology innovation program (201907056)Jinan clinical medical science and technology innovation program (202134018)National Natural Science Foundation of China (81870848, 82260031, 82171410)Rongxiang Regenerative Medicine Foundation of Shandong University (No. 2019SDRX-09)Youth Fund supported by Shandong Provincial Natural Science Foundation (ZR2020QC097)
6 · The paper itself

Abstract

Mesenchymal stem/stromal cells (MSCs) are spindle-like heterogeneous cell populations with advantageous bidirectional immunomodulatory and hematopoietic support effects. Vascular cellular adhesion molecule-1 (VCAM-1)

Indexed as

Mesenchymal Stem Cell TransplantationNeuroblastomaAnimalsHumansInfarction, Middle Cerebral ArteryNeuroprotectionNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisRatsRats, Sprague-DawleyUmbilical CordVascular Cell Adhesion Molecule-1NLR Family, Pyrin Domain-Containing 3 ProteinVascular Cell Adhesion Molecule-1Cerebral infarctionhUC-MSCsNeuroprotective effectNLRP3VCAM-1

Identifiers

PMID37336824
OpenAlexW4381193109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.